Penumbra (PEN) Long-Term Deferred Tax (2014 - 2026)
Penumbra (PEN) posted quarterly Long-Term Deferred Tax of $79.4 million for Q2 2026, down 27.27% year-over-year from $109.1 million in Q2 2025, and down 0.75% quarter-over-quarter from $80.0 million in Q1 2026.
Penumbra (PEN) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Long-Term Deferred Tax for 13 consecutive years, with $79.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 27.27% year-over-year to $79.4 million; the TTM figure through Jun 2026 stood at $79.4 million (down 27.27% YoY), while the FY2025 annual figure was $79.2 million, down 21.07% from the prior year.
- Long-Term Deferred Tax eased to $79.4 million in Q2 2026 per PEN's latest filing, from $80.0 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $109.1 million in Q2 2025 and bottomed at $62.8 million in Q3 2022.
- Historically, Long-Term Deferred Tax has averaged $82.8 million across 5 years, with a median of $79.7 million in 2026.
- Annual changes were most pronounced in 2024 — Long-Term Deferred Tax surged 64.78% — and 2026, when it retreated 27.27%.
- Penumbra's Long-Term Deferred Tax stood at $64.2 million in 2022, then soared by 32.62% to $85.2 million in 2023, then gained by 17.82% to $100.3 million in 2024, then dropped by 21.07% to $79.2 million in 2025, then grew by 0.24% to $79.4 million in 2026.
- Business Quant data shows PEN's Long-Term Deferred Tax at $79.4 million in Q2 2026, $80.0 million in Q1 2026, and $79.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.38 Mn |
| Mar 31, 2026 | 79.97 Mn |
| Dec 31, 2025 | 79.19 Mn |
| Sep 30, 2025 | 94.48 Mn |
| Jun 30, 2025 | 109.14 Mn |
| Mar 31, 2025 | 102.36 Mn |
| Dec 31, 2024 | 100.33 Mn |
| Sep 30, 2024 | 105.85 Mn |
| Jun 30, 2024 | 108.85 Mn |
| Mar 31, 2024 | 84.66 Mn |
| Dec 31, 2023 | 85.16 Mn |
| Sep 30, 2023 | 64.24 Mn |
| Jun 30, 2023 | 66.67 Mn |
| Mar 31, 2023 | 65.17 Mn |
| Dec 31, 2022 | 64.21 Mn |
| Sep 30, 2022 | 62.83 Mn |
| Jun 30, 2022 | 68.40 Mn |
| Mar 31, 2022 | 70.08 Mn |
| Dec 31, 2021 | 65.70 Mn |
| Sep 30, 2021 | 49.45 Mn |